Case Study of Drug Resistance in Two Children: Treatment Summary for Both Cases

This version of the course is no longer available.
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course . Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about (online CE course)
Case Study of Drug Resistance in Two Children: Treatment Summary for Both Cases

In the two cases discussed, treatment with LNZ and MOX appeared successful, despite a lack of official recommendation for both drugs in treating children. Second-line drugs have a high risk of adverse effects, such as bone marrow suppression and peripheral/optic neuropathy, as well as cutaneous, gastrointestinal, central nervous system (CNS), cardiac, and musculoskeletal damage. In the cases presented, the guardians understood the need to proceed aggressively and gave approval to use the drugs. The children were carefully monitored for complications and treatment failure.